(Q38167388)

30 August 2017

title

Environmental factors in multiple sclerosis (English)

1 reference

30 August 2017

0 references

1

Alberto Ascherio

1 reference

30 August 2017

publication date

1 December 2013

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

30 August 2017

published in

1 reference

30 August 2017

volume

13

1 reference

30 August 2017

issue

12 Suppl

1 reference

30 August 2017

page(s)

3-9

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

30 August 2017

1 reference

Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Vitamin D and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

The effect of infections on susceptibility to autoimmune and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

The hygiene hypothesis and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

The initiation and prevention of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Cigarette smoking and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Smoke exposure increases the risk for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Smoking and disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Body size and risk of MS in two cohorts of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Childhood body mass index and multiple sclerosis risk: a long-term cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Vitamin D as a protective factor in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2013.865866

10.1586/14737175.2013.865866

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference